US 11707472
Compositions for the treatment of fibrosis
granted A61KA61K31/19A61K31/662
Quick answer
US patent 11707472 (Compositions for the treatment of fibrosis) held by Viking Therapeutics, Inc. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Viking Therapeutics, Inc.
- Grant date
- Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/19, A61K31/662, A61K31/663, A61K31/664